CYTEIR THERAPEUTICS - Trademark Details
Status: 732 - Third Extension - Granted
Image for trademark with serial number 88510194
Serial Number
88510194
Word Mark
CYTEIR THERAPEUTICS
Status
732 - Third Extension - Granted
Status Date
2021-09-08
Filing Date
2019-07-11
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
011525, 260111, 260121, 260131, 261701, 261704, 261705, 261706 - Other natural phenomena and observable events. Letters, numerals, punctuation, geometric figures, objects, humans, plants or animals comprising a circle. Circles that are totally or partially shaded. Five or more circles. Straight line(s), band(s) or bar(s). Vertical line(s), band(s) or bar(s). Horizontal line(s), band(s) or bar(s). Diagonal line(s), band(s) or bar(s).
Published for Opposition Date
2020-02-25
Attorney Name
Law Office Assigned Location Code
M50
Employee Name
MARTIN, EUGENIA K
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"THERAPEUTICS"
Description of Mark
The mark consists of a circular pattern of dots resembling a starburst design, and the words "CYTEIR THERAPEUTICS" stacked to the right of the design on two lines of black font text, with the text on the first line in slightly larger font.
Goods and Services
pharmaceutical preparations for treatment of cancer and autoimmune diseases; pharmaceutical preparations for use in oncology, hematology, and immunology; synthetic lethal therapies for inducing destruction of diseased cells with DNA damage for medical treatment purposes
Goods and Services
Research and development of medical tests for analyzing synthetic lethality and DNA damage; research and development of synthetic lethal therapies and biomarkers of synthetic lethality; medical laboratory services; medical testing for scientific research purposes in the field of oncology, synthetic lethality, and DNA repair; providing medical and scientific research information in the fields of synthetic lethality, DNA repair, synthetic lethal therapies, oncology, hematology, and immunology; drug discovery services
Goods and Services
Medical testing for diagnostic or treatment services; medical testing services for developing personalized therapies
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-07-18
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-07-18
Primary Code
044
Current Trademark Owners
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Karen Won
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Continuity Child88982019
Trademark Events
Event DateEvent Description
2019-07-15NEW APPLICATION ENTERED IN TRAM
2019-07-18NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-07-19NOTICE OF DESIGN SEARCH CODE E-MAILED
2019-09-16TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
2019-09-23ASSIGNED TO LIE
2019-09-25APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2019-09-26ASSIGNED TO EXAMINER
2019-09-27NON-FINAL ACTION WRITTEN
2019-09-27NON-FINAL ACTION E-MAILED
2019-09-27NOTIFICATION OF NON-FINAL ACTION E-MAILED
2019-11-22TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2019-11-22ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-01-02TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-01-02CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-01-02TEAS/EMAIL CORRESPONDENCE ENTERED
2020-01-02TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-01-17APPROVED FOR PUB - PRINCIPAL REGISTER
2020-02-05NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-02-25PUBLISHED FOR OPPOSITION
2020-02-25OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-04-21NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2020-09-18TEAS EXTENSION RECEIVED
2020-09-18EXTENSION 1 FILED
2020-09-18EXTENSION 1 GRANTED
2020-09-22NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-03-01TEAS EXTENSION RECEIVED
2021-03-01TEAS REQUEST TO DIVIDE RECEIVED
2021-03-15CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-06-14CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-03-01DIVISIONAL REQUEST RECEIVED
2021-06-15DIVISIONAL PROCESSING COMPLETE
2021-03-01EXTENSION 2 FILED
2021-06-15EXTENSION 2 GRANTED
2021-06-16CORRECTED NOA E-MAILED
2021-06-16NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-09-08TEAS EXTENSION RECEIVED
2021-09-08EXTENSION 3 FILED
2021-09-08EXTENSION 3 GRANTED
2021-09-10NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED